Zhonghong Pulin Medical Products Co., Ltd. (SZSE:300981) commences a share repurchases on March 15, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on March 14, 2024. As per the mandate, the company is authorized to repurchase up to CNY 13.30 million worth of its shares. The shares will be repurchased at a price not more than CNY 15.15 per share.

The purpose of repurchase program is to maintain the company's value and shareholders' rights and interests. All the shares after this repurchase will be sold through centralized bidding or else it would be cancelled. The company will use its own funds to repurchase its shares.

The authorization will be valid for a period of 3 months from the date of approval.